The absolute efficacies of the live attenuated vaccine for these end points were 8% (95% CI, 194% to 67%) and 43% (95% CI, 15% to 71%). With serologic end points included, efficacy was demonstrated for the inactivated vaccine in a year with low influenza attack rates.
Download Image:
clickdownload
and right mouse click and Save image As...on new page
